LIFELAB 119
Welcome to the Spring edition of LifeLab. In this edition, you’ll read about early findings for a cutting-edge vaccine designed to provide protection against serious infection caused by the Epstein-Barr virus (EBV). We believe that this vaccine could be a big step forward in the prevention of multiple sclerosis (MS) and some cancers, as well as other recent discoveries across Cancer Research, Infection and Inflammation, Mental Health & Neuroscience and Population Health.